Cannell & Spears’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-116,630
| Closed | -$2.56M | – | 406 |
|
|
2025
Q1 | $2.56M | Sell |
116,630
-40,116
| -26% | -$882K | 0.06% | 174 |
|
|
2024
Q4 | $3.55M | Buy |
+156,746
| New | +$3.55M | 0.07% | 151 |
|
|
2024
Q3 | – | Sell |
-240,876
| Closed | -$7.02M | – | 411 |
|
|
2024
Q2 | $7.02M | Buy |
240,876
+220,588
| +1,087% | +$6.43M | 0.15% | 108 |
|
|
2024
Q1 | $719K | Buy |
+20,288
| New | +$719K | 0.01% | 249 |
|
|
2021
Q4 | – | Sell |
-4,785
| Closed | -$328K | – | 239 |
|
|
2021
Q3 | $328K | Hold |
4,785
| – | – | 0.02% | 180 |
|
|
2021
Q2 | $327K | Buy |
4,785
+1,159
| +32% | +$79.2K | 0.02% | 188 |
|
|
2021
Q1 | $251K | Sell |
3,626
-254
| -7% | -$17.6K | 0.02% | 202 |
|
|
2020
Q4 | $252K | Buy |
+3,880
| New | +$252K | 0.02% | 199 |
|
|
2020
Q3 | – | Sell |
-4,287
| Closed | -$201K | – | 236 |
|
|
2020
Q2 | $201K | Buy |
+4,287
| New | +$201K | 0.02% | 209 |
|